Command Palette

Search for a command to run...

UNICHEMLAB
478.65(-1.58%)
1W: +5.41%

Unichem Laboratories Peer Comparison

Snapshot Summary

Unichem Laboratories Ltd. shows promising growth with a solid valuation compared to peers, although profitability metrics indicate room for improvement. Companies like Cipla and Dr. Reddy's demonstrate stronger profitability and lower valuations, making them attractive options as well.

  • Unichem's revenue growth is robust at 26.94% YoY but has a negative PAT margin.
  • Cipla and Dr. Reddy's excel in profitability with strong ROE and lower PE ratios.
  • Divi's Laboratories, while having high EPS, shows a concerning decline in revenue growth.
  • Cipla is highly efficient with a strong cash flow and low debt, making it a leader in profitability.
  • Cipla Ltd.: Strong ROE and low PE ratio indicate high profitability and attractive valuation.
  • Dr. Reddy's Laboratories Ltd.: High ROE and efficient operations with low valuations make it a standout performer.
  • Mankind Pharma Ltd.: High revenue growth and good profitability metrics, although at a higher valuation.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
UNICHEMLAB₹502.15₹3,535.42Cr21.706.34%0.18
SUNPHARMA₹1,563.35₹3,75,099.26Cr87.5917.60%0.04
DIVISLAB₹6,091.05₹1,61,698.50Cr73.2016.46%-
CIPLA₹1,587.60₹1,28,217.27Cr23.7322.77%0.01
TORNTPHARM₹3,581.55₹1,21,215.77Cr61.5324.28%0.57
DRREDDY₹1,280.30₹1,06,835.27Cr15.5026.86%0.07
MANKIND₹2,518.95₹1,03,926.59Cr55.1828.38%0.02

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.